Recently posted guidance documents on Product Identifier Requirements Under the Drug Supply Chain Security Act, CGMP for Medical Gases, and Clinical Trials of Cellular and Gene Therapy Products

Recently Posted Guidance Documents

Drugs

6/30/2017 Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy Guidance for Industry

6/28/2017 Current Good Manufacturing Practice for Medical Gases

Cellular & Gene Therapy

6/27/2017 Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products; Guidance for Industry 

Guidance Document Search

• Search all FDA official guidance documents and other regulatory guidance